Bleeding News and Research

RSS

Study indicates that frogs in virus-exposed groups breed at young age

Frogs from groups exposed to a deadly virus are breeding at younger ages, new research suggests. Scientists studying European common frogs in the UK compared groups ("populations") exposed to ranavirus and those free from the disease.

20 Nov 2018

Purified omega-3 and aspirin reduce pre-cancerous bowel polyps, shows study

Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.

20 Nov 2018

Gum disease linked with diabetes

Gum disease and diabetes are chronic conditions that increase with age. The link between the two diseases goes both ways. It is thought that inflammation in the body is the connection- in fact, gum disease is the most common inflammatory disease.

14 Nov 2018

Mild exposure to single blast can induce meaningful pathogenic effects, study shows

As many as 300,000 United States service members deployed to Iraq and Afghanistan since 2001 have suffered traumatic brain injury due to explosions. The vast majority of these blast-induced traumatic brain injuries, or bTBIs, were classified as mild.

12 Nov 2018

Infant girls fed soy formula more likely to develop severe menstrual pain as adults, suggests research

New research suggests that infant girls fed soy formula are more likely to develop severe menstrual pain as young adults. The finding adds to the growing body of literature that suggests exposure to soy formula during early life may have detrimental effects on the reproductive system. The study appears online in the journal Human Reproduction.

9 Nov 2018

New oral drug reduces menstrual bleeding for women with common uterine tumors

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

9 Nov 2018

New trial investigates whether using water softeners can reduce eczema risk in babies

A clinical trial from the St John's Institute of Dermatology, School of Basic & Medical Biosciences has been launched to investigate whether using water softeners can reduce the risk of eczema in babies.

7 Nov 2018

Experts identify barriers to using stroke-preventing anticoagulants in Canada

International guidelines recommend direct oral anticoagulants over warfarin to prevent stroke for most patients with atrial fibrillation.

5 Nov 2018

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca will present 20 abstracts including a late-breaking oral presentation on the full results from the Phase III cardiovascular outcomes trial DECLARE -TIMI 58, the broadest SGLT2 inhibitor CVOT conducted to date, as well as new research from the Company's Cardiovascular, Renal & Metabolism therapy area at the American Heart Association Scientific Sessions, November 10-12, 2018, in Chicago, Illinois, USA.

1 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

CNIO researchers link MASTL protein to origin of thrombocytopenia

The Cell Division and Cancer Group of the Spanish National Cancer Research Centre has discovered that MASTL, the protein whose function in the organism has not yet been sufficiently investigated, plays an important role in controlling the cytoskeleton, the structure that gives shape to the cells, and enables their mobility and capacity for grouping.

1 Nov 2018

Minimally invasive surgery for cervical cancer may not be a good idea finds a pair of studies

New research shows that keyhole surgery or minimally invasive laparoscopic robotic surgery could be dangerous in the long run for women with cervical cancer. Unlike open surgeries, minimally invasive surgeries are being increasingly conducted and preferred because of their minimal tissue damage, minimal pain and risk as well as faster recovery.

1 Nov 2018

AEGEA Medical begins PACE II clinical study in women who underwent endometrial ablation

AEGEA Medical, Inc. has announced the commencement of the Post-Ablation Cavity Access (PACE II) clinical study in women who previously underwent endometrial ablation as part of AEGEA's pivotal trial of the company's patented Adaptive Vapor Ablation technology.

30 Oct 2018

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

Experimental vaccine shows promise to protect stroke survivors from blood clots

A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to new research in the American Heart Association's journal Hypertension.

29 Oct 2018

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

Stroke specialists often see conditions known as stroke "mimics" and "chameleons" that can complicate accurate diagnoses, Loyola Medicine neurologists report in the November 2018 issue of Neuroimaging Clinics of North America.

26 Oct 2018

King's researchers analyze potential risks of C-section

A series of papers published in the Lancet shows that globally the number of babies born through cesarean section (C-section) almost doubled between 2000 and 2015: from 12% to 21% of all births or nearly 30 million worldwide.

26 Oct 2018

FDA authorizes marketing of PicoAMH Elisa test to help determine woman's menopausal status

Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient's menopausal status.

25 Oct 2018

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie, a research-based global biopharmaceutical company, today announced positive results from U-ACHIEVE, an ongoing Phase 2b/3 dose-ranging study evaluating upadacitinib, an investigational JAK1-selective inhibitor, for induction and maintenance therapy in adult patients with moderately to severely active ulcerative colitis.

23 Oct 2018

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.

22 Oct 2018

Bleeding News and Research

Study indicates that frogs in virus-exposed groups breed at young age

Purified omega-3 and aspirin reduce pre-cancerous bowel polyps, shows study

Gum disease linked with diabetes

Mild exposure to single blast can induce meaningful pathogenic effects, study shows

Infant girls fed soy formula more likely to develop severe menstrual pain as adults, suggests research

New oral drug reduces menstrual bleeding for women with common uterine tumors

New trial investigates whether using water softeners can reduce eczema risk in babies

Experts identify barriers to using stroke-preventing anticoagulants in Canada

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

CNIO researchers link MASTL protein to origin of thrombocytopenia

Minimally invasive surgery for cervical cancer may not be a good idea finds a pair of studies

AEGEA Medical begins PACE II clinical study in women who underwent endometrial ablation

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

Experimental vaccine shows promise to protect stroke survivors from blood clots

Stroke 'mimics' and 'chameleons' can complicate accurate diagnoses

King's researchers analyze potential risks of C-section

FDA authorizes marketing of PicoAMH Elisa test to help determine woman's menopausal status

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News